durvalumab,tremelimumab
astrazeneca
[]
could we be talking chemo free neoadjuvant therapy in #esocsm?! small n (15) with significant #io toxicities. hope we can have more studies with greater numbers to answer this critical question #gi23 #gionc 
#FosterCare alum #GIonc #pallonc #survonc doc @ParkviewHealth.  #supponc #hpm #hapc. ✨#GI23 Featured Voice✨ ASCO FCOI https://t.co/4YWvppctiu